COc1ccc(-n2nc(C(=O)NCCc3cccc(C)c3)c3c4ccccc4n(C)c3c2=O)cc1Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?